InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,949.17
(
-0.60%
)
US TECH 100
20,283.20
(
-1.01%
)
Dow Jones
43,750.86
(
-0.47%
)
Brent Oil
72.21
(
0.48%
)
Bitcoin
87,075.60
(
-3.85%
)
Post# of 4984281
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

StockHighAlert-

Send PM Follow Ignore
Followers 128
Posts 23648
Boards Moderated 1
Alias Born 09/14/2016

StockHighAlert-

Re: None

Wednesday, 02/21/2018 9:51:16 AM

Wednesday, February 21, 2018 9:51:16 AM

Post# of 4984281
$RGBP News: Regen BioPharma Inc. (RGBP) and (RGBPP) has moved into the second stage of its previously-announced program to determine the three-dimensional structure of NR2F6 - with and without its proprietary small molecule drugs bound to it. The object of this structure-determination program is to shed light on how the small molecules bind to and modulate NR2F6 activity. https://finance.yahoo.com/news/regen-biopharma-inc-program-determine-130000690.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up